Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0115
0.00 (0.00%)
Feb 13, 2026, 9:30 AM EST

YBGJ Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
24361149-
Market Cap Growth
-93.46%-88.45%215.79%-76.90%--
Enterprise Value
35361352-
Last Close Price
0.010.030.300.100.42-
PS Ratio
-108879.941196.5559.45109.1639.60-
PB Ratio
-1.22-1.26-19.50-20.13-375.59-
EV/Sales Ratio
-1450.9160.25129.4341.43-
Debt / Equity Ratio
-0.86-0.21-0.21-1.40-20.530.27
Debt / FCF Ratio
-----5.38
Net Debt / Equity Ratio
-0.86-0.21-0.21-1.37-20.32-0.91
Net Debt / EBITDA Ratio
-1.27-0.38-0.38-0.66-1.751.53
Net Debt / FCF Ratio
-0.83-0.51-0.52-1.28-1.68-18.23
Asset Turnover
-0.000.300.030.350.76
Inventory Turnover
-1.690.690.213.66-
Quick Ratio
0.160.100.110.140.211.42
Current Ratio
0.250.140.210.300.381.49
Return on Equity (ROE)
-----297.65%-85.95%
Return on Assets (ROA)
-60.18%-77.36%-37.19%-21.72%-27.43%-24.90%
Return on Capital Employed (ROCE)
78.30%62.20%69.10%689.00%-85.80%-61.00%
Earnings Yield
-56.51%-42.76%-3.33%-10.59%-3.13%-
FCF Yield
--32.22%-2.06%-5.28%-3.22%-
Buyback Yield / Dilution
-959.17%-900.00%89.91%-0.50%-1.94%-1058.84%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.